Reported Consolidated quarterly numbers for Bliss GVS Pharma are:Net Sales at Rs 198.13 crore in March 2024 up 7.22% from Rs. 184.78 crore in March 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 9.15 crore in March 2024 down 373.57% from Rs. 3.34 crore in March 2023.
EBITDA stands at Rs. 33.95 crore in March 2024 up 268.62% from Rs. 9.21 crore in March 2023.
Bliss GVS shares closed at 129.40 on May 02, 2024 (NSE) and has given 33.95% returns over the last 6 months and 68.27% over the last 12 months.
| Bliss GVS Pharma | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'24 | Dec'23 | Mar'23 | | Net Sales/Income from operations | 198.13 | 200.72 | 184.78 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 198.13 | 200.72 | 184.78 | | EXPENDITURE | | Consumption of Raw Materials | 87.28 | 90.97 | 77.53 | | Purchase of Traded Goods | 7.98 | 7.55 | 1.21 | | Increase/Decrease in Stocks | 0.21 | 3.97 | 30.25 | | Power & Fuel | -- | -- | -- | | Employees Cost | 24.51 | 24.29 | 22.51 | | Depreciation | 6.85 | 6.95 | 4.88 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 49.80 | 30.25 | 47.05 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 21.50 | 36.74 | 1.36 | | Other Income | 5.60 | 5.42 | 2.98 | | P/L Before Int., Excpt. Items & Tax | 27.10 | 42.16 | 4.33 | | Interest | 1.85 | 2.12 | 5.08 | | P/L Before Exceptional Items & Tax | 25.25 | 40.04 | -0.75 | | Exceptional Items | -29.20 | -- | -- | | P/L Before Tax | -3.95 | 40.04 | -0.75 | | Tax | 0.96 | 10.97 | -4.22 | | P/L After Tax from Ordinary Activities | -4.91 | 29.07 | 3.46 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -4.91 | 29.07 | 3.46 | | Minority Interest | -4.23 | -1.46 | -0.12 | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -9.15 | 27.61 | 3.34 | | Equity Share Capital | 10.47 | 10.47 | 10.42 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.88 | 2.64 | 0.34 | | Diluted EPS | -0.86 | 2.60 | 0.33 | | EPS After Extra Ordinary | | Basic EPS | -0.88 | 2.64 | 0.34 | | Diluted EPS | -0.86 | 2.60 | 0.33 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
